Most sold healthcare stocks in Q3 2022
See which Healthcare stocks institutional investors trimmed or exited the most in Q3 2022, measured as net reductions in reported share positions from Q2 2022 into Q3 2022. Notable reductions at the top of this list include BAUSCH HEALTH COS INC (BHC), BOSTON SCIENTIFIC CORP (BSX), CENTENE CORP (CNC), PRECIGEN INC (PGEN). These rankings are based on SEC 13F filings from the investors we track.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| BHC | BAUSCH HEALTH COS INC | -15,889,036 | -$187.21K | 0 | 0 | 1 | 2 | 3 |
| BSX | BOSTON SCIENTIFIC CORP | -14,170,888 | -$504.36K | 2 | 1 | 1 | 1 | 4 |
| CNC | CENTENE CORP | -6,768,854 | -$583.13K | 1 | 0 | 1 | 1 | 2 |
| PGEN | PRECIGEN INC | -6,255,998 | -$7.73K | 0 | 0 | 1 | 1 | 1 |
| ALHC | ALIGNMENT HEALTHCARE INC | -5,326,239 | -$60.14K | 0 | 1 | 1 | 0 | 2 |
| CI | THE CIGNA GROUP | -4,560,779 | -$1.03M | 0 | 0 | 3 | 0 | 4 |
| EVH | EVOLENT HEALTH INC - A | -3,912,829 | -$108.46K | 0 | 0 | 1 | 0 | 1 |
| GILD | GILEAD SCIENCES INC | -3,805,997 | -$242.61K | 0 | 4 | 3 | 0 | 7 |
| ISRG | INTUITIVE SURGICAL INC | -3,395,347 | -$689.63K | 0 | 2 | 3 | 0 | 5 |
| NVS | NOVARTIS AG-SPONSORED ADR | -3,395,058 | -$692.10K | 0 | 0 | 5 | 1 | 6 |
| BMY | BRISTOL-MYERS SQUIBB CO | -2,613,684 | -$6.16M | 0 | 2 | 9 | 1 | 12 |
| CLDX | CELLDEX THERAPEUTICS INC | -2,311,966 | -$62.30K | 1 | 0 | 0 | 1 | 1 |
| MRK | MERCK & CO. INC. | -2,230,721 | -$5.39M | 0 | 2 | 8 | 0 | 14 |
| NVO | NOVO-NORDISK A/S-SPONS ADR | -2,221,820 | -$428.36K | 0 | 0 | 2 | 0 | 3 |
| BLUE | BLUEBIRD BIO INC | -2,052,890 | -$6.84K | 0 | 0 | 1 | 0 | 1 |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | -2,026,656 | -$56.95K | 0 | 0 | 0 | 1 | 0 |
| ME | 23ANDME HOLDING CO -CLASS A | -1,816,300 | -$4.03K | 1 | 0 | 1 | 0 | 3 |
| EXEL | EXELIXIS INC | -1,753,093 | -$119.00K | 0 | 0 | 1 | 0 | 2 |
| DOCS | DOXIMITY INC-CLASS A | -1,744,798 | -$64.92K | 0 | 1 | 2 | 0 | 3 |
| PRCT | PROCEPT BIOROBOTICS CORP | -1,545,000 | -$50.51K | 0 | 0 | 0 | 1 | 0 |
| ZOM | ZOMEDICA CORP | -1,507,000 | -$341 | 0 | 0 | 1 | 1 | 1 |
| AMLX | AMYLYX PHARMACEUTICALS INC | -1,400,000 | $24.34K | 0 | 0 | 1 | 0 | 1 |
| SNY | SANOFI-ADR | -1,348,099 | -$983.28K | 0 | 2 | 3 | 0 | 5 |
| OPK | OPKO HEALTH INC | -1,159,915 | -$4.75K | 0 | 0 | 1 | 1 | 1 |
| NUVL | NUVALENT INC-A | -1,110,170 | -$15.05K | 0 | 0 | 0 | 1 | 0 |
| CGEM | CULLINAN THERAPEUTICS INC | -1,097,319 | -$14.07K | 0 | 1 | 1 | 0 | 2 |
| ABCL | ABCELLERA BIOLOGICS INC | -1,055,500 | -$13.51K | 0 | 0 | 1 | 0 | 1 |
| GDRX | GOODRX HOLDINGS INC-CLASS A | -1,024,000 | -$8.84K | 0 | 0 | 1 | 0 | 1 |
| TGTX | TG THERAPEUTICS INC | -1,001,900 | -$3.96K | 0 | 0 | 1 | 0 | 1 |
| ABBV | ABBVIE INC | -970,121 | -$161.81K | 0 | 4 | 3 | 0 | 10 |
| MRNA | MODERNA INC | -960,153 | -$186.04K | 1 | 1 | 2 | 0 | 5 |
| CAH | CARDINAL HEALTH INC | -949,515 | $14.03K | 0 | 1 | 3 | 1 | 5 |
| MGNX | MACROGENICS INC | -921,700 | -$2.46K | 0 | 0 | 1 | 0 | 1 |
| DHR | DANAHER CORP | -913,967 | -$190.65K | 0 | 3 | 2 | 1 | 9 |
| ATOS | ATOSSA THERAPEUTICS INC | -894,285 | -$1.26K | 0 | 0 | 1 | 0 | 1 |
| DXCM | DEXCOM INC | -888,672 | -$66.20K | 0 | 0 | 1 | 0 | 1 |
| AMGN | AMGEN INC | -835,273 | -$225.29K | 0 | 1 | 6 | 0 | 7 |
| ZTS | ZOETIS INC | -792,833 | -$370.77K | 0 | 1 | 7 | 1 | 9 |
| BKD | BROOKDALE SENIOR LIVING INC | -784,116 | -$5.64K | 0 | 1 | 1 | 0 | 2 |
| ZLAB | ZAI LAB LTD-ADR | -780,195 | -$28.32K | 0 | 0 | 2 | 0 | 2 |
| INCY | INCYTE CORP | -762,450 | -$297.33K | 0 | 0 | 3 | 1 | 3 |
| IONS | IONIS PHARMACEUTICALS INC | -739,080 | $27.65K | 0 | 1 | 2 | 0 | 3 |
| SPRO | SPERO THERAPEUTICS INC | -724,317 | -$267 | 0 | 0 | 1 | 0 | 1 |
| A | AGILENT TECHNOLOGIES INC | -715,961 | -$68.57K | 0 | 1 | 2 | 1 | 4 |
| CORT | CORCEPT THERAPEUTICS INC | -636,400 | -$1.75K | 0 | 0 | 1 | 0 | 1 |
| QSI | QUANTUM-SI INC | -631,294 | -$22.54K | 0 | 0 | 1 | 0 | 1 |
| OCGN | OCUGEN INC | -621,856 | -$1.41K | 0 | 0 | 0 | 1 | 0 |
| PHG | KONINKLIJKE PHILIPS NVR- NY | -598,668 | -$21.27K | 0 | 1 | 1 | 0 | 2 |
| OSUR | ORASURE TECHNOLOGIES INC | -592,476 | $356 | 0 | 0 | 1 | 0 | 1 |
| CMRX | CHIMERIX INC | -573,840 | -$1.26K | 0 | 0 | 1 | 0 | 1 |
Frequently asked questions about Most sold healthcare stocks in Q3 2022
What are the most sold Healthcare stocks in Q3 2022?
The most sold healthcare stocks in Q3 2022 are those with the largest decrease in reported share counts across tracked institutional investors compared to Q2 2022, based on SEC 13F filings.
Which healthcare stocks did institutional investors trimmed or exited the most in Q3 2022?
Among the managers we track, net reductions were largest in companies such as BAUSCH HEALTH COS INC (BHC), BOSTON SCIENTIFIC CORP (BSX), CENTENE CORP (CNC), based on aggregated 13F data.
How is institutional selling calculated?
Selling is calculated by summing the net decrease in shares reported by tracked investors between two consecutive quarterly 13F snapshots (compared to Q2 2022).
Does this include all institutional owners?
These rankings are based on a subset of tracked institutional investors who file SEC 13F reports. While not exhaustive, the dataset includes many of the largest and most influential funds.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.